Mithra launches an offering of up to EUR 150 million convertible bonds due 2025


Liege, Belgium, 10 December 2020 – 08:00 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to women’s health, announces today the launch of an offering (the “Offering”) of senior unsecured convertible bonds due 17 December 2025 (the “Bonds”), for an initial aggregate principal amount of EUR 125 million with an increase option of up to EUR 25 million to be exercised at the discretion of the Company before pricing.